Approvals Action

Pfizer vs Humira

Posted 1 March 2021 

Pfizer's Abrilada has been approved by the TGA adding to a growing list of adalimumab biosimilars marketed in Australia.

Available as solution for injection vial, pre-filled pen and pre-filled syringe, Abrilada is indicated for the same inflammatory diseases as AbbVie's originator Humira.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here